Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis ; volume:15 ; number:1 ; day:13 ; month:1 ; year:2024 ; pages:1-15 ; date:1.2024
Cell death & disease ; 15, Heft 1 (13.1.2024), 1-15, 1.2024
- Urheber
-
Lee, Dong Min
Kim, In Young
Lee, Hong Jae
Seo, Min Ji
Cho, Mi-Young
Lee, Hae In
Yoon, Gyesoon
Ji, Jae-Hoon
Park, Seok Soon
Jeong, Seong-Yun
Choi, Eun Kyung
Choi, Yong Hyeon
Yun, Chae-Ok
Yeo, Mirae
Kim, Eunhee
Choi, Kyeong Sook
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-024-06434-x
- URN
-
urn:nbn:de:101:1-2024032609495764623673
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
02.04.2025, 01:08 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Dong Min
- Kim, In Young
- Lee, Hong Jae
- Seo, Min Ji
- Cho, Mi-Young
- Lee, Hae In
- Yoon, Gyesoon
- Ji, Jae-Hoon
- Park, Seok Soon
- Jeong, Seong-Yun
- Choi, Eun Kyung
- Choi, Yong Hyeon
- Yun, Chae-Ok
- Yeo, Mirae
- Kim, Eunhee
- Choi, Kyeong Sook
- SpringerLink (Online service)
Ähnliche Objekte (12)
VCF1 is a p97/VCP cofactor promoting recognition of ubiquitylated p97-UFD1-NPL4 substrates
Investigation of the interaction of FAT10 and VCP (p97)
WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97/VCP axis
Valosin-containing protein (VCP/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage
Valosin-containing protein (VCP/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage
Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitors
VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy
A systematic proteomic approach to the VCP/p97-cofactor interaction landscape reveals p97 functions in stress response signaling
The FAM104 proteins VCF1/2 promote the nuclear localization of p97/VCP
UBXD1 is a mitochondrial recruitment factor for p97/VCP and promotes mitophagy
ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97
Targeting the immunoproteasome and VCP/p97 in autoimmune disorders and viral infection
VCF1 is a p97/VCP cofactor promoting recognition of ubiquitylated p97-UFD1-NPL4 substrates
Investigation of the interaction of FAT10 and VCP (p97)
WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97/VCP axis
Valosin-containing protein (VCP/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage
Valosin-containing protein (VCP/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage
Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitors
VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy
A systematic proteomic approach to the VCP/p97-cofactor interaction landscape reveals p97 functions in stress response signaling
The FAM104 proteins VCF1/2 promote the nuclear localization of p97/VCP
UBXD1 is a mitochondrial recruitment factor for p97/VCP and promotes mitophagy
ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97
Targeting the immunoproteasome and VCP/p97 in autoimmune disorders and viral infection
VCF1 is a p97/VCP cofactor promoting recognition of ubiquitylated p97-UFD1-NPL4 substrates
Investigation of the interaction of FAT10 and VCP (p97)
WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97/VCP axis
Valosin-containing protein (VCP/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage
Valosin-containing protein (VCP/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage
Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitors
VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy
A systematic proteomic approach to the VCP/p97-cofactor interaction landscape reveals p97 functions in stress response signaling
The FAM104 proteins VCF1/2 promote the nuclear localization of p97/VCP
UBXD1 is a mitochondrial recruitment factor for p97/VCP and promotes mitophagy
ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97